Search results for RNAtherapy
RNAtherapy community
One keyword maps to one global community path.
People
Not Found
Tweets including RNAtherapy
🚀 Advances in targeted drug delivery are boosting oncotherapy by improving RNA, siRNA, ASO & CRISPR delivery for cancer treatment!
🌍 Join us at OTDC 2026
📅 25–26 May 2026 | Rome, Italy
🔗
#OTDC2026# #DrugDelivery# #Oncotherapy# #RNAtherapy# #Biotech#
Show more
Advances in Sustainable #Oligonucleotide# Manufacturing
...
#Oligonucleotides#
#RNAtherapeutics#
......
Breaking the mold with #RNA—a# “ #RNAissance# ” of life science.
.
#RNAtherapeutics#
#RNAdrugs#
#Oligonucleotides#
#mRNAtherapeutics#
#mRNA#
#siRNA#
#RNAi#
#Antisenseoligonucleotides#
#Antisenseoligonucleotides#
#ASO#
#NucleicAcids#
.
Show more
#Extracellularvesicles#, genetic programmers.
Next delivery systems for #RNAtherapeutics#
#Exosomes#
Advancing cancer treatment through oligonucleotide-based therapies from siRNA & ASOs to innovative delivery systems driving precision oncology.
🌍OTDC 2026
🗓️ 25–26 May 2026 | 📍 Rome, Italy
🔗
#OTDC2026# #RNATherapeutics# #Oligonucleotides# #CancerResearch#
Show more
🧬 Exploring how genetics-driven drug discovery is shaping RNA-based antivirals against SARS-CoV-2 from antitargets to delivery challenges.
Join the discussion at the OTDC-2026
📍Rome, Italy |🗓️May 25–26, 2026
🔗
#RNAtherapeutics# #Genomics# #DrugDiscovery#
Show more
AI is transforming oligonucleotide design and drug delivery excited to be part of it!
📅 Conference: OTDC (2026)
📍 Location: Rome, Italy
🗓 Dates: May 25–26, 2026
🌐 Website:
#RNAtherapeutics# #DrugDelivery# #AIinPharma# #Oligonucleotides# #HealthcareAI#
Show more
Peptide-based supramolecular nanoassemblies are advancing precision gene therapy and diagnostics, enabling more efficient and targeted oligonucleotide delivery.
📍 OTDC 2026 – Rome, Italy
📅 May 25–26, 2026
🌐
#OTDC2026# #GeneTherapy# #RNAtherapeutics#
Show more
Narrowing down the candidates of beneficial A-to-I #RNAediting# by comparing the recoding sites with uneditable counterparts.
#ADAR#
#RNAtherapeutics#
#AstraZeneca# and #IonisPharmaceutical# are the first to receive FDA approval for the #antisenseoligonucleotide# (ASO) based RNA drug #eplontersen#.
The only treatment for the treatment of PN transthyretin-mediated amyloidosis (hATTR-PN).
.
#RNAtherapeutics#
.
Show more